|
$243,332
|
To analyze the Georgia Medicaid program?s new payment models for contraceptive access
|
2020 - 2022
|
LJAF
|
|
$181,083
|
To examine how prescription drugs can be developed by a nonprofit company.
|
2020 - 2022
|
LJAF
|
|
$300,000
|
To examine key factors that impact the availability of long acting reversible contraceptive methods at Federally Qualified Health Centers and disseminating key findings.
|
2018 - 2019
|
LJAF
|
